AnticoagEvaluator
org.acc.AnticoagEvaluator
Total installs
500+
Rating
2.3(3 reviews)
Released
March 6, 2013
Last updated
November 21, 2024
Category
Medical
Developer
American College of Cardiology
Developer details
Name
American College of Cardiology
E-mail
unknown
Website
https://www.acc.org/education-and-meetings/products-and-resources/ncd-academy
Country
unknown
Address
unknown
Screenshots




Description
Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com